Tang Capital Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.89M | Hold |
281,200
| – | – | 0.45% | 58 |
|
|
2025
Q1 | $9.33M | Hold |
281,200
| – | – | 0.52% | 48 |
|
|
2024
Q4 | $9.68M | Hold |
281,200
| – | – | 0.64% | 44 |
|
|
2024
Q3 | $11.2M | Hold |
281,200
| – | – | 0.8% | 42 |
|
|
2024
Q2 | $8.48M | Hold |
281,200
| – | – | 0.86% | 38 |
|
|
2024
Q1 | $9.44M | Buy |
281,200
+10,000
| +4% | +$336K | 0.98% | 36 |
|
|
2023
Q4 | $8.76M | Hold |
271,200
| – | – | 0.81% | 34 |
|
|
2023
Q3 | $8.89M | Hold |
271,200
| – | – | 1.25% | 25 |
|
|
2023
Q2 | $9.54M | Sell |
271,200
-50,000
| -16% | -$1.76M | 1.41% | 23 |
|
|
2023
Q1 | $10.5M | Buy |
321,200
+40,000
| +14% | +$1.31M | 1.56% | 20 |
|
|
2022
Q4 | $15.5M | Sell |
281,200
-28,800
| -9% | -$1.59M | 2.25% | 14 |
|
|
2022
Q3 | $13.7M | Buy |
310,000
+10,000
| +3% | +$443K | 1.68% | 20 |
|
|
2022
Q2 | $14.6M | Hold |
300,000
| – | – | 2.22% | 13 |
|
|
2022
Q1 | $14.6M | Buy |
+300,000
| New | +$14.6M | 2.92% | 10 |
|